Ddu College — China’s Import and Export Report of Peptic Ulcer Drugs


Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain.
There is an increasing number of people with irregular diets due to the accelerated pace of modern life. Thus, more and more people suffer from peptic ulcer diseases, stimulating the need for peptic ulcer drugs.
Today, Ddu, the leading global pharmaceutical & medical device B2B online platform, will be sharingChina’s Import and Export Report of Peptic Ulcer Drugs with you.
I. Global situation of peptic ulcer drugs market
The sales of peptic ulcer drugs account for the biggest part of digestive system drugs and according to the classification of the European Pharmaceutical Research Market Association, they can be divided into the following 5 categories:
Proton Pump Inhibitor
H2-antagonists
Bismuth Preparations
Prostaglandins
Others
According to IMS statistics, the global market of peptic ulcer drugs in 2016 was 20.83 billion USD. The market share of the main products are shown in the following chart.
Source: IMS
PPI became the main treatment for ulcers due to its fast-acting, long-lasting effects and good acid suppression.
The global proton pump inhibitor (PPI) market was 18.146 billion USD in 2016, accounting for 87.2% of the global market for peptic ulcer drugs.
In addition to this, omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole were the leading products in peptic ulcer drugs market.
Source: PDB, CNKI
Currently, the key markets for peptic ulcer drugs are Europe, North America and Asia.
The Chinese market ranked first amongst the Asian markets with 1.125 billion USD. The chart below indicates the markets for other regions.
Source: PDB, CNKI
II. Chinese peptic ulcer drugs market
Different from those in global markets, peptic ulcer drugs in the Chinese market are mainly divided into the following categories:
Proton Pump Inhibitors
H2-antagonists
Mucosal Protective Agents
Others
According to the statistics of PDB, the Chinese peptic ulcer drugs market is growing year by year with a market size exceeding 7.43 billion RMB in 2016 and is expected to reach 8 billion RMB in 2017.
2014-2017 Growth Trend of Global Market of Anti-Peptic Ulcer Drugs (100 Million RMB)
Proton pump inhibitors (PPI) accounted for 91.8% of the Chinese peptic ulcer drugs market H2-antagonists 4.3%, Mucosal Protective Agents 2.1% and others 1.8%.
As indicated on the chart below, PPIs dominate the market followed by omeprazole for injection (45%), pantoprazole for injection (37%), lansoprazole for injection (12%) and esomeprazole for injection (6%).
Source: PDB
According to the statistics of PDB, public hospitals in major cities in China spent 4.5 billion RMB on PPIs in 2016, an increase of 6% over the previous year. Lansoprazole ranked first with market sales of 1.239 billion RMB, an increase of 5.52 %.
III. China’s imports of peptic ulcer drugs
Domestically manufacture generic drugs are taking the place of imported peptic ulcer drugs. Thus, imported peptic ulcer drugs only accounted for 16.7% of the peptic ulcer drugs market with a total import of 1.24 billion RMB.
China mainly imported esomeprazole, omeprazole and hydrotalcite from AstraZeneca and Bayer.
PPI esomeprazole (Nexium) from AstraZeneca took up a comparatively big share of China’s imported drugs. The chart below indicates China’s peptic ulcer drug imports of 2016.
Source: PDB
IV. China’s export of peptic ulcer drugs
With the encouragement of the national industrial policy and the support of technological developments, China’s export market of peptic ulcer drugs is developing rapidly with growing exports.
According to the statistics of China custom, exports of pantoprazole sodium and omeprazole are as follows:
Source: China Custom
V. Chinese leading peptic ulcer drugcompanies
  • Cisen Pharmaceutical Co., Ltd
Cisen Pharmaceutical Co., Ltd is a comprehensive chemical manufacturing enterprise in China, one of the top 100 Chinese pharmaceutical industry companies and a national high-tech company.
Representative product: Pantoprazole sodium enteric-coated tablets, omeprazole for injection, omeprazole enteric-coated tablets and Lansoprazole tablets
Indications: Duodenal ulcer and gastric ulcer
Main exporting regions: Pakistan, Angola, Venezuela, Nicaragua and others
  • Jiangsu Aosaikang pharmaceutical Co., Ltd
Jiangsu Aosaikang pharmaceutical Co., Ltd is a research-based pharmaceutical enterprise that integrates and streamlines innovative research and development with manufacturing, marketing promotions and sales of proprietary pharmaceuticals, fine chemicals and health care products.
Representative product: Omeprazole sodium for injection and lansoprazole for injection
Indications: Peptic ulcer and hemorrhage
Main exporting regions: USA
  • Youcare Pharmaceutical Group Co., Ltd.
Youcare Pharmaceutical Group Co., Ltd. is involved in pharmaceutical drugs research and development, pharmaceutical manufacturing, distribution and sales, and foreign trade as one of the private pharmaceutical enterprise groups.
Representative product: Omeprazole enteric-coated capsules
Indications: Gastric ulcer and duodenal ulcer
Main exporting regions: More than 40 countries and regions such as Russia, Pakistan, Germany, Africa, Latin America
VI. There is a great potential market for pantoprazole
Due to social development, environmental changes, population structures and people's lifestyles, the incidence of peptic ulcers caused by smoking, drinking, emotional stress and drug stimulation is getting higher and higher. In China and around the world, the number of patients with peptic ulcer disease is rapidly increasing. Thus, prevention and treatment of peptic ulcer disease has become an urgent matter.
Ddu, the leading global pharmaceutical & medical device B2B online platform, believes that pantoprazole, as a new generation of proton pump inhibitors, is more stable than that of mono alkoxyl pyridine and has better selective effect on parietal cells. Moreover, compared with omeprazole and lansoprazole, pantoprazole is safer and more effective when used in combination with other drugs and has good anti-acid secretion effects. Therefore, pantoprazole is a highly selective H+，K+-ATP enzyme inhibitor with good curative effects and minimal side effect.
For more information, please visit http://cn.media.drugdu.com/
www.drugdu.com
source：http://medicaldeviceandequipment.33236.n8.nabble.com/Ddu-College-China-s-Import-and-Export-Report-of-Peptic-Ulcer-Drugs-td39.html

评论

发表评论

此博客中的热门博文

The future of lung function tests for COPD

With the global increase of  lung diseases  such as asthma, severe bronchitis and emphysema,  lung function tests  are becoming a bigger concern for many people. Spirometry  (measuring lung function) is the most well know  pulmonary function test  and vital to diagnose  COPD . Some of the diseases which can be detected are: 1. Chronic obstructive pulmonary disease (COPD) – main term used to describe lung diseases such as asthma, emphysema, chronic bronchitis etc. 2. Asthma – common and long-term lung disease characterised by coughing, shortness of breath or wheezing. 3. Chronic bronchitis – bronchial tubes become inflamed and produce an excessive amount of mucus. 4. Emphysema – long-term progressive disease where alveoli in the lungs become inflamed causing shortness of breath. 5. Cystic fibrosis – genetic lung disease characterised by frequent lung infections and coughing up mucus as a result of this. 6. Pulmonary fibrosis - interstitial lungdiseases resulting in the
阅读全文

Consumption of Crickets Support the Growth of Beneficial Gut Bacteria

图片
Valerie Stull, a doctoral graduate from the University of Wisconsin-Madison Nelson Institute for Environmental Studies published the results of her study on the benefits of consuming crickets on gut bacteria in the journal  Scientific Reports.  It is not only safe at high doses but may also reduce inflammation in the body Valerie Stull said that she was 12 when she ate her first insect. She said,  “I was on a trip with my parents in Central America and we were served fried ants; I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food — and it was good!” Stull further added,  “There is a lot of interest right now in edible insects; It’s gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock.” Tiffany Weir, the co-corresponding author and a professor of food science and human nutrition at Colorado State University said,  “Thi
阅读全文

Press Conference for Ddu Credit Verification Launch

According to official Ddu news, the leading global pharmaceutical and medical device B2B online platform and SGS-CSTC (Standards Technical Services Co., Ltd.) will be calling a press conference in Shenzhen, China, on August 18, 2017 to launch their strategic partnership on credit verification and kick off the Ddu Credit Verification Service officially. In recent years, the cross-border medical trade in China has seen rapid development, however due to certain factors such as lack of integrity, time lags and remote regions, it has been difficult for buyers and suppliers to determine the quality of the trade which could lead to contract fraud, counterfeit and inferior goods as well as payment delinquencies and false transaction. To tackle these problems, a signing ceremony for strategic cooperation on credit verification will be held by Ddu and SGS-CSTC to officially launch the project. Yuan Shimin, CEO of Ddu, together with high priority members across the country, will gather to
阅读全文